Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$2.67 -0.09 (-3.26%)
At close: Nov 11, 2026 · 4:00 PM EST

Eledon Pharmaceuticals (ELDN) Restructuring Costs (2020)

Updated

Eledon Pharmaceuticals (ELDN) recorded Restructuring Costs of $2.3 million in FY2021, up 0.8% from $2.28 million in FY2020.

Analysis

Eledon Pharmaceuticals (ELDN) Restructuring Costs (2020) Analysis & Trends

  • Per Business Quant data, ELDN's Restructuring Costs was $2.28 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Eledon Pharmaceuticals 313.62 Mn 224.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -10,000.00
Sep 30, 2020 1.80 Mn
Jun 30, 2020 490,000.00
API Access

Eledon Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ELDN&period=max&api_key=YOUR_API_KEY